Cercar
01/01/2026
Adverse events associated with the use of flumazenil in the Emergency Department
Ramos, JR, Peláez, MG, Clemente, YC, Requejo, CC, Alcón, EV, Mora, JRR, Blanch, CT, Palomares, AG, Costas, DG. Adverse events associated with the use of flumazenil in the Emergency Department. MEDICINA CLINICA. 2026; 166(1)DOI:10.1016/j.medcli.2025.107312. PMID:41534387. IF:2.100(Q2/3D).
31/12/2025
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis
Calle, C, Elez, E, Manzano, JL, Moreno-Martinez, ME, Pericay, C, Graefenhain, R, Ariznavarreta, A, Lizan, L. Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis. Journal Of Pharmaceutical Policy And Practice. 2025; 18(1)DOI:10.1080/20523211.2025.2567970. PMID:41415036. IF:(Q/D).
01/01/2024
Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.
Vilarrasa E, Nicolau J, de la Cueva P, Goday A, Gallardo F, Martorell A, Carrascosa JM. Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.. Actas Dermo-Sifiliograficas. 2024; 115(1)DOI:10.1016/j.ad.2023.06.017. PMID:37451337. IF:(Q/D).
01/01/2024
Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients.
Escolà H, Llombart B, Escolà-Rodríguez A, Barchino-Ortiz L, Marcoval J, Alcaraz I, Beà-Ardébol S, Toll A, Miñano-Medrano R, Rodríguez-Jiménez P, López-Nuñez M, Ferrándiz-Pulido C, Jaka A, Masferrer E, Aguayo-Ortiz RS, Yébenes M, Arandes-Marcocci J, Ruiz-Salas V, Turrión-Merino L, Just M, Sánchez-Schmidt J, Leal L, Mayo-Martínez F, Haya-Martínez L, Sandoval-Clavijo A, Dradi GG, Delgado Y, Verdaguer-Faja J, López-Castillo D, Pujol RM, Deza G. Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(1)DOI:10.1016/j.jaad.2023.08.088. PMID:37704106. IF:11.800(Q1/1D).